Clinical Trials Browser

Observational × Metastatic Hormone-sensitive Prostate Cancer × 1 year × Clear all

NCT05901649 2026-03-13

ArtemisPRO

Active not recruiting

Metastatic Hormone-sensitive Prostate Cancer

NCT06874114 2025-09-02

RE-ENGAGE

Active not recruiting

Metastatic Hormone-sensitive Prostate Cancer

NCT07031258 2025-06-22

Evaluation of the Efficacy of Darolutamide Triplet Therapy in Patients With Metastatic Hormone-sensitive Prostate Cancer

Not yet recruiting

Metastatic Hormone-sensitive Prostate Cancer